These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37599880)

  • 1. Slouching towards engagement: interactions between people using psychedelics naturalistically and their healthcare providers.
    Boehnke KF; Cox K; Weston C; Herberholz M; Glynos N; Kolbman N; Fields CW; Barron J; Kruger DJ
    Front Psychiatry; 2023; 14():1224551. PubMed ID: 37599880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturalistic Psychedelic Use: A World Apart from Clinical Care.
    Glynos NG; Fields CW; Barron J; Herberholz M; Kruger DJ; Boehnke KF
    J Psychoactive Drugs; 2023; 55(4):379-388. PubMed ID: 35950817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically.
    Kruger DJ; Glynos NG; Fields CW; Herberholz M; Boehnke KF
    J Psychoactive Drugs; 2023; 55(4):420-424. PubMed ID: 36328419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychologists' and psychotherapists' knowledge, attitudes, and clinical practices regarding the therapeutic use of psychedelics.
    Kucsera A; Suppes T; Haug NA
    Clin Psychol Psychother; 2023; 30(6):1369-1379. PubMed ID: 37394242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "How Do I Learn More About this?": Utilization and Trust of Psychedelic Information Sources Among People Naturalistically Using Psychedelics.
    Kruger DJ; Enghoff O; Herberholz M; Barron J; Boehnke KF
    J Psychoactive Drugs; 2023; 55(5):631-639. PubMed ID: 37078418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study.
    Song-Smith C; Jacobs E; Rucker J; Saint M; Cooke J; Schlosser M
    BMJ Open; 2024 Mar; 14(3):e083595. PubMed ID: 38485474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Relationship Between Naturalistic Psychedelic Use and Clinical Care in Canada.
    Glynos NG; Kruger DJ; Kolbman N; Boehnke K; Lucas P
    J Psychoactive Drugs; 2023; 55(5):660-671. PubMed ID: 37516904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychedelic Experiences During the Early COVID-19 Pandemic: Findings From an International Online Survey.
    Evens R; Reiche S; Marek RM; Moon DU; Groß RE; Romanello A; Jalilzadeh Masah D; Scicchitano Böckheler M; Gutwinski S; Montag C; Mick I; Majić T
    Front Psychiatry; 2021; 12():732028. PubMed ID: 34803757
    [No Abstract]   [Full Text] [Related]  

  • 9. Medical student attitudes and perceptions of psychedelic-assisted therapies.
    Li I; Fong R; Hagen M; Tabaac B
    Front Psychiatry; 2023; 14():1190507. PubMed ID: 37441143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferences and Support for Psychedelic Policies and Practices Among Those Using Psychedelics.
    Kruger DJ; Barron J; Herberholz M; Boehnke KF
    J Psychoactive Drugs; 2023; 55(5):650-659. PubMed ID: 37353935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psychedelics and treatment of mental disorders: A survey of attitudes and knowledge among psychiatrists, general practitioners and psychologists in Iceland].
    Olafsson RP; Kvaran K; Ketilsdottir K; Hallgrimsdottir K; Sigurdsson EL; Sigurdsson E
    Laeknabladid; 2023 Nov; 109(11):495-503. PubMed ID: 37909445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microdosing psychedelics: Motivations, subjective effects and harm reduction.
    Lea T; Amada N; Jungaberle H; Schecke H; Klein M
    Int J Drug Policy; 2020 Jan; 75():102600. PubMed ID: 31778967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey.
    Garcia-Romeu A; Davis AK; Erowid E; Erowid F; Griffiths RR; Johnson MW
    Front Psychiatry; 2019; 10():955. PubMed ID: 32038317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of classic psychedelics among adults: a Danish online survey study.
    Søgaard Juul T; Ebbesen Jensen M; Fink-Jensen A
    Nord J Psychiatry; 2023 May; 77(4):367-378. PubMed ID: 36173202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.
    Barnett BS; Greer GR
    J Acad Consult Liaison Psychiatry; 2021; 62(4):460-471. PubMed ID: 34210406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.
    Bender D; Hellerstein DJ
    Psychopharmacology (Berl); 2022 Jun; 239(6):1907-1932. PubMed ID: 35022823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory Survey.
    Barnett BS; Beaussant Y; King F; Doblin R
    J Psychoactive Drugs; 2022; 54(3):269-277. PubMed ID: 34409921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice.
    Gorman I; Nielson EM; Molinar A; Cassidy K; Sabbagh J
    Front Psychol; 2021; 12():645246. PubMed ID: 33796055
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.